Haemorheological treatment of ischaemia--facts or fancy?
作者信息
Ernst E
出版信息
J R Soc Med. 1991 Nov;84(11):639-40. doi: 10.1177/014107689108401102.
Abstract
摘要
相似文献
1
Haemorheological treatment of ischaemia--facts or fancy?缺血性疾病的血液流变学治疗——事实还是幻想？
J R Soc Med. 1991 Nov;84(11):639-40. doi: 10.1177/014107689108401102.
2
Haemorheological treatment of ischaemia--facts or fancy?缺血的血液流变学治疗——事实还是幻想？
J R Soc Med. 1992 Jun;85(6):365.
3
4
The rheological efficiency of parenteral pentoxifylline (Trental) in patients with ischemic brain lesions. Preliminary results.缺血性脑损伤患者静脉注射己酮可可碱（曲克芦丁）的流变学疗效。初步结果。
Eur Neurol. 1983;22 Suppl 1:98-104. doi: 10.1159/000115657.
5
[Hemodilution, hemorheology and oxygen supply].
Acta Med Austriaca. 1991;18 Suppl 1:3-8.
6
[Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
Wien Med Wochenschr. 1986;136 Spec No:29-35.
7
[Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Acta Med Austriaca. 1991;18 Suppl 1:23-7.
8
[Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
Acta Med Austriaca. 1991;18 Suppl 1:20-2.
9
Pharmacology of pentoxifylline, a hemorheologic agent for the treatment of intermittent claudication.己酮可可碱的药理学，一种用于治疗间歇性跛行的血液流变学药物。
Angiology. 1984 Jul;35(7):407-17. doi: 10.1177/000331978403500703.
10
[The importance of clinical hemorheology in the study of cerebral blood flow in normal conditions and in cerebrovascular ischemia].[临床血液流变学在正常状态及脑血管缺血时脑血流研究中的重要性]
Arq Neuropsiquiatr. 1995 Mar;53(1):157-68. doi: 10.1590/s0004-282x1995000100025.
本文引用的文献
1
Effect of hematocrit on venous return.血细胞比容对静脉回流的影响。
Circ Res. 1961 Jan;9:157-64. doi: 10.1161/01.res.9.1.157.
2
Therapeutic defibrinogenation in peripheral vascular disease.外周血管疾病中的治疗性去纤维蛋白原法
Int Angiol. 1985 Jul-Sep;4(3):373-7.
3
Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.己酮可可碱。对其药效学和药代动力学特性以及治疗效果的综述。
Drugs. 1987 Jul;34(1):50-97. doi: 10.2165/00003495-198734010-00003.
4
Placebo-controlled, double-blind study of haemodilution in peripheral arterial disease.外周动脉疾病血液稀释的安慰剂对照双盲研究。
Lancet. 1987 Jun 27;1(8548):1449-51. doi: 10.1016/s0140-6736(87)92204-5.
5
Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group.
Circulation. 1989 Dec;80(6):1549-56. doi: 10.1161/01.cir.80.6.1549.
6
[Hemorheologic therapy. Status and perspectives].[血液流变学治疗。现状与展望]
Nervenarzt. 1989 Sep;60(9):528-39.
7
[Hemodilution in cerebral ischemia. Farewell to a common treatment concept].
Dtsch Med Wochenschr. 1989 Mar 3;114(9):350-4. doi: 10.1055/s-0029-1235650.
8
Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP).在接受肝素诱导的体外低密度脂蛋白沉淀（HELP）治疗的患者中，血液流变学改善与血浆纤维蛋白原和低密度脂蛋白降低有关。
Eur J Clin Invest. 1989 Feb;19(1):30-7. doi: 10.1111/j.1365-2362.1989.tb00192.x.
9
Plasma fibrinogen--an independent cardiovascular risk factor.血浆纤维蛋白原——一种独立的心血管危险因素。
J Intern Med. 1990 Jun;227(6):365-72. doi: 10.1111/j.1365-2796.1990.tb00174.x.
10
A double-blind trial of Dextran-haemodilution vs. placebo in claudicants.右旋糖酐血液稀释与安慰剂治疗间歇性跛行患者的双盲试验。
J Intern Med. 1990 Jan;227(1):19-24. doi: 10.1111/j.1365-2796.1990.tb00113.x.
Zotero 插件